Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-035347

Chairman & CEO bought 7,000 shares at $7.63 ($53,410)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BENTSUR RON Chairman & CEO 2022-03-17 Purchase +7,000 $7.63 $53,410 2,821,459 D: show line 1 in the form
Open-market purchases · 7,000 sh · avg $7.63 · $53,410
Loading xslF345X03/tm229700-1_4.xml…